“The aim of medicine is to prevent disease and prolong life, the ideal of medicine is to eliminate the need of a

physician.”
-William James Mayo
Onco b. Hormonal therapy

1. The leading cause of cancer-related mortality is: c. Immunologic therapy

a. Colorectal cancer d. Brachytherapy

b. Breast cancer 6. Chemotherapy given before locoregional

treatment to decrease tumor size:
c. Lung cancer
a. Primary therapy
d. Pancreatic cancer
b. Neoadjuvant therapy
2. Prevention of cancer in a person who does not
have the disease: c. Adjuvant therapy

a. Primary prevention d. Concurrent chemotherapy

b. Secondary prevention 7. Response to cancer treatment where there is an

appearance of new tumor lesion:
c. Tertiary prevention
a. Complete response
d. Digital rectal examination
b. Progressive disease
3. All are strategies for secondary cancer
prevention, EXCEPT: c. Partial response

a. Pap smear test d. Stable response

b. Mammography 8. This is the desired response to cancer treatment

if the goal is to cure:
c. Hepatitis vaccination
a. Complete response
d. Digital rectal examination
b. Stable response
4. This is the desired response to cancer treatment
if the goal is to palliate: c. Partial response

a. Complete response d. Progressive disease

b. Stable response 9. Screening for colorectal cancer, except:

c. Partial response a. Digital rectal examination

d. Progressive disease b. Colonoscopy

5. All are systemic forms of cancer treatment, c. Fecal occult blood test
except:
d. Serum CEA
a. Cytotoxic therapy

1
“The aim of medicine is to prevent disease and prolong life, the ideal of medicine is to eliminate the need of a
physician.”
-William James Mayo
10. This is the desired response to cancer treatment b. Pancreatic cancer
if the goal is to control:
c. Colon cancer
a. Complete response
d. Cervical cancer
b. Stable response
15. Radiation delivered by sealed radioactive
c. Partial response material injected near or at the tumor site:

d. Progressive disease a. Brachytherapy

11. All are forms of locoregional treatment of b. Teletherapy

cancer, except:
16. Level of cancer prevention which involved
a. Indigestion or dysphagia screening tests to detect subclinical cancer:

b. Anemia secondary to bleeding a. Primary prevention

c. Changes in bladder habits b. Secondary prevention

d. Weight loss > 10% in 6 months c. Tertiary prevention

12. All are forms of locoregional treatment of d. Quaternary prevention

cancer, except:
17. Level of cancer prevention which involved
a. Cobalt treatment clinical treatment of cancer:

b. Surgery a. Primary

c. Brachytherapy b. Secondary

d. Gene therapy c. Tertiary

13. Chemotherapy given after a locoregional d. Quaternary

treatment to prolong survival:
18. Most frequent adverse effects of cytotoxic
a. Primary therapy drugs, except:

b. Adjuvant chemotherapy a. Bone marrow suppression

c. Neoadjuvant chemotherapy b. Neurotoxicity

d. Palliative therapy c. Nausea and vomiting

14. The following are cancers where screening d. Alopecia

effectively detects early disease, except:
19. Cancer grade with the worst prognosis:
a. Breast cancer
a. Grade 1

2
“The aim of medicine is to prevent disease and prolong life, the ideal of medicine is to eliminate the need of a
physician.”
-William James Mayo
b. Grade 2 1. Part of the screening program for prostate
cancer
c. Grade 3
a. PSA
d. Grade 4
b. Digital rectal examination
20. Which is not included in the surgical-pathologic
staging of cancer: c. Transrectal ultrasound

a. Primary tumor characteristics d. All of these

b. Nodal involvement 2. What is the treatment for superficial bladder

Ca?
c. Patient functional status
a. Radical cystectomy
d. Absence or presence of metastasis
b. TURB + intravesical BCG
21. Which of the following is the most significant
risk factor for malignancy? c. Transurethral resection of bladder
(TURB)
a. Sex
d. TURB + intravesical BCG + RT
b. Age
3. Which of the chemotherapeutic drug is active
c. Race against bladder Ca?
d. Weight a. Doxorubicin
Midterms: Dr. Ferrolino b. Gemcitabine
1. Risk factors for breast cancer, except: c. 5FU
a. BRCA mutations d. Cisplatin
b. Nulliparity 4. Gynecologic malignancy with the highest
c. Early pregnancy mortality

d. Late menopause a. Endometrial Ca

2. The most powerful prognostic indicator in b. Ovarian Ca

breast cancer: c. Cervical Ca
a. Tumor size d. Germ cell tumor
b. Histological grade 5. The most common histology of bladder cancer
c. Axillary lymph node status a. Adenocarcinoma
Finals 2006
3
“The aim of medicine is to prevent disease and prolong life, the ideal of medicine is to eliminate the need of a
physician.”
-William James Mayo
b. Transitional carcinoma 10. Most common histologic type of
nasopharyngeal Ca
c. Squamous cell carcinoma
a. Keratinizing squamous cell Ca
d. Clear cell Ca
b. Undifferentiated Ca
6. A patient with ovarian Ca Stage 2 underwent
suboptimal debulking. What is your next plan of c. Non-keratinizing Squamous cell Ca
treatment:
d. Adenocarcinoma
a. Post-op RT
11. Prognostic factors for prostate Ca, except
b. Post-op chemo RT
a. PSA
c. Post-op chemotherapy
b. Stage
d. No further treatment
c. Gleason score
7. What is the most common histology for ovarian
Ca? d. Family history

a. Mucinous cystadenocarcinoma 12. Protective factors for ovarian cancer

b. Serous cystadenocarcinoma a. Nulliparity

c. Germ cell tumor b. Oral contraceptive

d. None of the above c. Infertility

8. Most cancers of the prostate develop in the d. BRCA mutations

13. Tumor marker important in monitoring

a. Peripheral zone of the prostate
recurrence of ovarian Ca
b. Central zone
a. CA 19-9
c. Transition zone
b. CA 125
d. None of the above
c. B-HCG
9. What is the treatment for a 75 y/o patient with
stage 3 prostate Ca and DM? d. LDH

a. Radical prostatectomy 14. Not a risk factor for endometrial cancer

b. TURP + RT a. Hypertension

c. TURP b. Anovulatory menstrual cycle

d. RT with or w/o hormonal therapy c. Polycystic ovary disease

4
“The aim of medicine is to prevent disease and prolong life, the ideal of medicine is to eliminate the need of a
physician.”
-William James Mayo
d. Pregnancy a. Stage of the disease

15. Most important risk factor for head and neck b. Histologic grade
tumors
c. Extent of residual disease
a. Alcohol
d. All of the above
b. Radiation
20. A 50 y/o patient is diagnosed as endometrial
c. Smoking hyperplasia.

d. Vitamin A deficiency a. Watchful waiting

16. Most common histology of head and neck b. Oral progestin

tumors.
c. TAHBSO
a. Adenocarcinoma
d. No treatment
b. Squamous cell carcinoma
21. Risk factors for cervical Ca, except
c. Undifferentiated carcinoma
a. Genital warts
d. Adenoid cystic carcinoma
b. Multiparity
17. Which gynecologic malignancy is clinically
staged? c. Fertility drugs

a. Ovarian Ca 22. Site of laryngeal Ca with the best prognosis

b. Endometrial Ca a. Supraglottic

c. Cervical Ca b. Subglottic

d. Germ cell tumor c. Glottic

18. The most common presentation of endometrial d. All are good prognosis
Ca 23. Treatment of choice for stage 1 endometrial Ca
a. Palpable pelvic mass a. TAHBSO
b. Abnormal vaginal bleeding b. Hormonal therapy
c. Abnormal pap smear c. RT
d. Foul vaginal discharge d. Chemotherapy
19. Which of the following are predictive factors of 24. Active drugs against ovarian Ca, except
outcome of ovarian Ca?
a. Taxane

5
“The aim of medicine is to prevent disease and prolong life, the ideal of medicine is to eliminate the need of a
physician.”
-William James Mayo
b. Cisplatin 29. The following constitutes a proper staging
laparotomy, except
c. Carboplatin
a. Omentectomy
d. 5FU
b. Radical hysterectomy
25. Standard of care for metastatic prostate Ca,
Except c. Lymph node dissection

a. GNRH agonist d. Peritoneal washings and cytology

b. Anti-androgen 30. The main treatment for salivary gland tumors

c. Bilateral orchiectomy a. Surgery

d. RT b. Surgery + RT

26. Most common metastatic site of prostate Ca c. RT

a. Bladder d. Chemotherapy

b. Colon Oncology Compiled Recalls

Midterms 2013
c. Liver Dr. E. Lim

d. Bone 1. Breast Histopath associated with bilateral breast Ca

A. Invasive Ductal Carcinoma
27. Treatment of choice for increasing PSA level in a B. Invasive Lobular Carcinoma
prostate Ca patient with NO other evidence of C. Ductal Carcinoma In Situ
disease D. Lobular Carcinoma In Situ

a. Hormonal therapy 2. Treatment of choice for stage 3 T2N M0:

A. Chemo--‐Sx--‐Chemo
b. Watchful waiting
3. Screening for young patient with BRCA1 mutation
c. RT A. UTZ
B. mammogram
d. Chemotherapy
C. Chest XrAY
D. MRI
28. Majority of endometrial Ca on presentation is in
what stage? 4. good prognosis
A. ER--‐ PR--‐
a. Stage 1
B. ER--‐ PR--‐ HER2--‐
b. Stage 2 C. ER+ PR--‐
D. ER+ PR+ HER2+
c. Stage 3
5. Breast CA surveillance guidelines:
d. Stage 4 A. CXR
B. Bone scan
6
“The aim of medicine is to prevent disease and prolong life, the ideal of medicine is to eliminate the need of a
physician.”
-William James Mayo
C. UTZ of liver C. Single chemo > Combination
D. Pelvic Exam D. Chemo RT > RT or Chemo alone?

6. Treatment for Stage III CA 14. diffuse gastric cancer:

A. Neoadjuvant chemo +Surgery + adjuvant A. Young patients
B. Surgery + adjuvant B. good prognosis
C. Neoadjuvant + surgery +surveillance C. ulcerative
D. surgery +surveillance D. common in antrum and lesser curvature

7. Treatment for type III NSCLC 15. most common site of gastric CA:
A. Surgery + adjuvant A. Distal part
B. Neoadjuvant + surgery + adjuvant B. fundus
C. Chemo RT C. pyloric
D. Chemo alone D. ?

8. Minimum number of LN sample in colonic resection 16. Risk factor for gastric CA
A. 10 A. Menetier’s Dse
B. 11 B. duodenal ulcer
C. 12 C. BTB
D. 14 D. Low social economic status

9. Colon cancer invading the muscularis propia, negative 17. Pre malignant polyp:
for mets 3 out of 16 LN positive. What is the best A. Juvenile polyp
treatment? B. Hyperplasia
A. Surgery C. Adenocarcinoma
B. Surgery + foxfili/foxfire D. hamartoma
C. Surgery + foxfili/foxfire + RT
D. _____ 18. Metastatic to the ovary:
Krukenberg
10. side effect of cetuximab:
A. rashes 19. True of gastric CA:
B. diarrhea A. squamous cell is most common
C. bleeding B. Diffuse type has better outcome than intestinal type
D. hypertension C. Anemia is a risk factor
D. Odynophagia & early satiety is a common
11. Most common symptom of esophageal ca: manifestation of intestinal type
Odynophagia
20. Premalignant:
12. Etiologic agent/factor of esophageal cancer: A. 2.5 in size
A. Pernicious anemia B. tubulous
B. Menetier’s Dse C. villous
C. Nitrates D. pedunculated
D. H. pylori

13. Esophageal Ca, locally advanced stage. Benefits of

Sx, Chemo and RT
A. RT > Sx alone
B.????
7
“The aim of medicine is to prevent disease and prolong life, the ideal of medicine is to eliminate the need of a
physician.”
-William James Mayo
FINALS 2013 b.
ONCO – FINALS 2013
c. S. mansoni
1. Diffuse gastric cancer
d. chronic carboplatin use
a. young patient

b. good prognosis 8. Nulliparity a risk factor:

c. ulcerative a. Ovarian Ca

d. common in antrum and lesser curvature b. Enfometrial Ca

c. Cervical Ca
2. Most common presentation of Lung Ca:

A. dyspnea

B. cough

C. weight loss

D. chest pain

3. Complete disappearance after treatment:

A. complete

B. partial

C. stable

D. progressive

4. Screened at early stage Cervical Ca

5. Clinically diagnosed  Cervical Ca

6. High propensity for bilateral breast Cancer

a. invasive ductal carcinoma

b. invasive lobular carcinoma

c. lobular CIS

d. ----------

7. Bladder Ca

a. Anilline dyes